Ankylosing spondylitis trials in China

In China 24 Also abroad 89

24 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1Not yet taking people in China
A Study of GKL-006Allo Injection in Patients With Ankylosing Spondylitis
Where
Beijing
Age
18 years to 65 years
People
12
Run by
Beijing Gene Key Life Technology Co., Ltd
See details and how to joinNCT07915544
Phase 2Taking people
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Where
Beijing, Bengbu, Changchun, Guangzhou, Kunming, Luoyang, Pingxiang, Ürümqi
Age
18 years to 80 years
People
315 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07133633 · EU 2025-521059-21-00
No phaseTaking people
A Randomized Trial of Ultrasound-Guided Acupotomy for Ankylosing Spondylitis
Where
Henan
Age
18 years to 75 years
People
60
Run by
China-Japan Friendship Hospital
See details and how to joinNCT07578220
No phaseEnrolling by invitation
Mass Spectrometry-based Immune Profiling in Autoimmune Diseases
Where
Beijing
Age
18 years and over
People
500
Run by
Peking University People's Hospital
See details and how to joinNCT07188285
No phaseTaking people
Multicenter Validation of the 2025 Classification Criteria for Axial Spondyloarthritis
Where
Beijing
Age
18 years to 45 years
People
247
Run by
Chinese PLA General Hospital
See details and how to joinNCT07724847
Phase 1Not yet taking people in China
Safety and Efficacy of Allogeneic Bone Marrow MSCs in Ankylosing Spondylitis
Where
Shenzhen
Age
18 years to 40 years
People
40
Run by
Eighth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT07632599
Phase 4Not yet taking people in China
Effectiveness and Safety of Acemetacin in Active Axial Spondyloarthritis: A Real-world Study
Where
Beijing
Age
18 years to 65 years
People
150
Run by
Chinese PLA General Hospital
See details and how to joinNCT07582146
No phaseTaking people
Evaluating the Efficacy and Short-Term Prognosis of Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis(AS): A Protocol for a Cohort Study
Where
Beijing
Age
18 years to 75 years
People
790
Run by
China-Japan Friendship Hospital
See details and how to joinNCT07556224
No phaseTaking people
The Disease Progression of Chinese Axial Spondyloarthritis in a Real-word Cohort Study
Where
Beijing
Age
18 years and over
People
2,250
Run by
China-Japan Friendship Hospital
See details and how to joinNCT06844643
No phaseTaking people
Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis (AS): A Cohort Study Protocol Focusing on Spondyloarthritis Research Consortium of Canada (SPARCC) Scoring System
Where
Beijing
Age
18 years to 75 years
People
210
Run by
China-Japan Friendship Hospital
See details and how to joinNCT07509775
Phase 4Taking people
A Study Evaluating the Efficacy of Secukinumab 300mg in Chinese Adults With Active Ankylosing Spondylitis
Where
Wuhan
Age
18 years to 80 years
People
100
Run by
Tongji Hospital
See details and how to joinNCT05303285
Phase 3Not yet taking people in China
A Study to Evaluate the Efficacy and Safty of 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)
Where
Beijing
Age
18 years and over
People
380
Run by
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
See details and how to joinNCT07349329
Phase 2/3Not yet taking people in China
Efficacy and Safety of Xeligekimab in the Treatment of Non-Radiographic Axial Spondyloarthritis
Where
Wuhan
Age
18 years and over
People
40
Run by
Lingli Dong
See details and how to joinNCT07339566
Phase 3Taking people
Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.
Where
Beijing
Age
18 years to 70 years
People
420
Run by
Jiangsu vcare pharmaceutical technology co., LTD
See details and how to joinNCT07172360
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS)
Where
Beijing
Age
18 years and over
People
500
Run by
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
See details and how to joinNCT07261644
Phase 3Taking people
A Study to Evaluate Efficacy and Safety of LNK01001 in Adults With Ankylosing Spondylitis
Where
Beijing
Age
18 years and over
People
352
Run by
Lynk Pharmaceuticals Co., Ltd
See details and how to joinNCT07237568
Phase 4Taking people
Effect and Safety of Benzathine Penicillin Combined With Etanercept on Spondyloarthritis
Where
Chongqing, Ganzhou, Guangzhou, Hefei, Hohhot
Age
18 years to 59 years
People
340
Run by
Nanfang Hospital, Southern Medical University
See details and how to joinNCT06707194
Phase 3Taking people
A Trial of SHR-1314 Injection in Adult Patients With Active Non-radiographic Axial Spondyloarthritis
Where
Beijing
Age
18 years and over
People
380
Run by
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
See details and how to joinNCT06860750
No phaseTaking people
Bidirectional Cohort Study of Nanfang Spondyloarthritis
Where
Guangzhou
Age
10 years to 59 years
People
3,000
Run by
Nanfang Hospital, Southern Medical University
See details and how to joinNCT06988813
Phase 2Taking people
A Study to Evaluate 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)
Where
Beijing, Chongqing, Nanjing, Shenzhen, Zhengzhou
Age
18 years and over
People
180
Run by
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
See details and how to joinNCT06222671
Phase 4Not yet taking people in China
Interleukin-17 (IL-17) Inhibitor in Combination With Tumor Necrosis Factor α (TNFα )Inhibitor for the Treatment of Ankylosing Spondylitis
Where
Guiyang
Age
18 years and over
People
10
Run by
The Affiliated Hospital Of Guizhou Medical University
See details and how to joinNCT06833112
No phaseNot yet taking people in China
A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.
Where
Hangzhou
Age
18 years and over
People
10,000
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06766552
Phase 3Taking people
A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and Placebo
Where
Beijing, Kunming, Lanzhou, Luoyang, Nanchong, Shijiazhuang, Suzhou, Tianjin, Wuhan
Age
18 years to 65 years
People
408
Run by
Tasly Pharmaceutical Group Co., Ltd
See details and how to joinNCT06000956
No phaseTaking people
Effects of Nonsteroidal Anti-Inflammatory Drugs in Recurrence of Spondyloarthritis Patients After Remission
Where
Xiamen
Age
18 years and over
People
140
Run by
The First Affiliated Hospital of Xiamen University
See details and how to joinNCT03425812